Top Clicks This Month

Not Intended for Therapeutic Use. For research use only.

Tetrodotoxin - CAS 4368-28-9

Quick Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Category
Inhibitor
Product Name
Tetrodotoxin
Catalog Number
4368-28-9
Synonyms
TTx
CAS Number
4368-28-9
Description
Tetrodotoxin, frequently abbreviated as TTX, is a potent neurotoxin. Its name derives from Tetraodontiformes, an order that includes pufferfish, porcupinefish, ocean sunfish or mola, and triggerfish; several species that carry the toxin. Although tetrodotoxin was discovered in these fish and found in several other animals (e.g., blue-ringed octopus, rough-skinned newt, and Naticidae) it is actually produced by certain symbiotic bacteria, such as Pseudoalteromonas tetraodonis, certain species of Pseudomonas and Vibrio, as well as some others that reside within these animals. Tetrodotoxin inhibits the firing of action potentials in nerves by binding to the voltage-gated sodium channels in nerve cell membranes and blocking the passage of sodium ions (responsible for the rising phase of an action potential) into the nerve cell.
Molecular Weight
319.27
Molecular Formula
C11H17N3O8
Quantity
Milligrams-Grams
Quality Standard
Enterprise Standard
COA
Certificate of Analysis-Tetrodotoxin 4368-28-9 B15J0509  
MSDS
Inquire
Target
Sodium Channel
Structure
CAS 4368-28-9 Tetrodotoxin
Specification
Purity
80%, 98%
Appearance
White lyophilised solid
Application
For research used only
Related Sodium Channel Products
  • CAS 4368-28-9 Tetrodotoxin

    Tetrodotoxin
    (CAS: 4368-28-9)

    Tetrodotoxin, frequently abbreviated as TTX, is a potent neurotoxin. Its name derives from Tetraodontiformes, an order that includes pufferfish, porcupinefish, ...

  • Evenamide
    (CAS: 1092977-61-1)

    Evenamide is a selective voltage-gated sodium and​/or calcium channel modulator, including subtypes Nav1.3, Nav1.7, and Nav1.8. It may be potentia useful in pre...

  • Sodium Channel inhibitor 1
    (CAS: 1198117-23-5)

    Sodium Channel inhibitor 1, a 3-Oxoisoindoline-1-carboxamide derivative, is an effective voltage-gated sodium channel blocker that could be used for pain treatm...

  • CAS 95635-55-5 Ranolazine

    Ranolazine
    (CAS: 95635-55-5)

    Ranolazine is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

  • Triamterene D5
    (CAS: 1189922-23-3)

    The isotope labbelled form of Triamterene which is an inhibitor of ENaC and could be used as a weak diuretic.

  • ICA-121431
    (CAS: 313254-51-2)

    ICA-121431 is a potent and selective inhibitor of human NaV1.3 (IC50=13 nM) and NaV1.1 channels (IC50=23 nM) with 1,000 fold selectivity against other resistant...

  • CAS 550-83-4 Propoxycaine hydrochloride

    Propoxycaine hydrochloride
    (CAS: 550-83-4)

    Propoxycaine hydrochloride is the hydrochloride salt form of Propoxycaine used to control the pain of intramuscular injection of penicillin as well as in dentis...

  • CAS 132112-35-7 Ropivacaine Hydrochloride

    Ropivacaine Hydrochloride
    (CAS: 132112-35-7)

    Ropivacaine hydrochloride is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.

  • GS967
    (CAS: 1262618-39-2)

    GS967, also known as GS-458967, is a highly selective late sodium channel current blocker. The selective inhibition of late INa with GS967 can exert antiarrhyth...

  • XEN907
    (CAS: 912656-34-9)

    XEN907 is a novel spirooxindole NaV1.7 blocker with IC50 of 3 nM. It shows a further 10-fold increase in potency, which represents a promising structure for fur...

  • GSK-1014802 hydrochloride
    (CAS: 934240-31-0)

    GSK-1014802 hydrochloride is the hydrochloride form of GSK-1014802, which is a novel analgesic for the treatment of lumbosacral radiculopathy (sciatica) and tri...

  • CAS 54143-56-5 Flecainide Acetate

    Flecainide Acetate
    (CAS: 54143-56-5)

    Flecainide Acetate is an antiarrhythmic as a Na+ channel blocker that inhibits fast Na+ current in cardiac muscle

  • Eleclazine
    (CAS: 1443211-72-0)

    Eleclazine is a selective Sodium channel antagonist. Eleclazin showed a shortening of the QTc interval (the time interval between the start of the Q-wave and en...

  • PF-04856264
    (CAS: 1235397-05-3)

    This active molecular is a human Nav1.7 voltage gated sodium channel inhibitor with the IC50 value of 28 nM. PF-04856264 inhibits the Nav channel by interacting...

  • CAS 84057-84-1 Lamotrigine

    Lamotrigine
    (CAS: 84057-84-1)

    Lamotrigine is an anticonvulsant, inhibiting glutamate release, possibly through inhibition of Na+, K+ and Ca2+ currents.

  • CAS 944261-79-4 A-803467

    A-803467
    (CAS: 944261-79-4)

    A-803467 is a sodium channel blocker that potently blocks tetrodotoxin-resistant currents (IC50=140 nM).

  • CAS 5875-06-9 Proxymetacaine hydrochloride

    Proxymetacaine hydrochloride
    (CAS: 5875-06-9)

    Proparacaine Hydrochloride is a topical ophthalmic anesthetic, acting by inhibiting the voltage-gated sodium channels. IC50(ED50): 3.4 mM.

  • CAS 630-93-3 Phenytoin Sodium

    Phenytoin Sodium
    (CAS: 630-93-3)

    Phenytoin Sodium is a potent multi-channel blocker, which blocks Na+, K+ and Ca 2+ channels and selectively blocks persistent INaP over shorter INaP actions.

  • Nav1.7 inhibitor
    (CAS: 1355631-24-1)

    Nav1.7 inhibitor is a Voltage-gated sodium channel inhibitor that have probable effect in pain therapy and local anaesthesia.

  • CAS 6160-12-9 (-)-Sparteine sulfate pentahydrate

    (-)-Sparteine sulfate pentahydrate
    (CAS: 6160-12-9)

    (-)-Sparteine sulfate pentahydrate is an alkaloid compound which could be used as in the treatment of antiarrhythmic by blocking sodium channel.

Reference Reading
1. Optimization of simultaneous analysis of tetrodotoxin, 4-epitetrodotoxin, 4,9-anhydrotetrodotoxin, and 5,6,11-trideoxytetrodotoxin by hydrophilic interaction liquid chromatography–tandem mass spectrometry
Mari Yotsu-Yamashita • Jun-Ho Jang • Yuko Cho • Keiichi Konoki. Forensic Toxicol (2011) 29:61–64
Tetrodotoxin (TTX) is one of the most important natural toxins being encountered especially in Japan. It is the primary toxin in puffer fish poisoning, acting as a powerful and specific voltage-gated sodium channel blocker. Many analogs of TTX, such as 4-epiTTX, 4,9-anhydroTTX, 11-norTTX-6(S)-ol, 11-norTTX-6(R)-ol, 5-deoxyTTX, 11-deoxyTTX, 6,11-dideoxyTTX, 5,6,11-trideoxyTTX, 4-cysteinylTTX, 11-oxoTTX, and tetrodonic acid have been found in puffer fish. Among them, 5,6,11-trideoxyTTX, 4-epiTTX, and 4,9-anhydroTTX, the latter two of which are chemically interchangeable with TTX, are the major analogs of TTX (Fig. 1). The LD50 (50% lethal dose, mice, intraperitoneal injection) of TTX was determined to be 10 lg/kg, and we previously reported that the dissociation constants (Ko) for the interactions of TTX, 4-epiTTX, 4,9-anhydroTTX, and 5,6,11-trideoxyTTX with the rat synapse membrane were 1.8, 68, 180, and [5000 nM, respectively.
2. Differential Effects of Tityus bahiensis Scorpion Venom on Tetrodotoxin-Sensitive and Tetrodotoxin-Resistant Sodium Currents
Eder R. Moraes • Evanguedes Kalapothakis • Lıgia A. Naves • Christopher Kushmerick. Neurotox Res (2011) 19:102–114
Mammalian sodium channels form a family of proteins with differential tissue distributions and pharmacological properties. Nine sodium channel pore-forming alpha subunits genes have been identified thus far, denominated NaV1.1–NaV1.9 (Catterall et al. 2003). The muscle isoforms, NaV1.4 and NaV1.5, are expressed in skeletal and cardiac myocytes, respectively. Splice variants of NaV1.5 are also expressed in the brain (Wang et al. 2009). The remaining isoforms are expressed predominantly in the central nervous system (NaV1.1, NaV1.2, NaV1.3, NaV1.6), peripheral nervous system (NaV1.7, NaV1.8), or both (NaV1.9). Sodium channels can also be classified based on their sensitivity to tetrodotoxin (TTX). Channels formed by NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.6, NaV1.7 alpha subunits are blocked by nanomolar concentrations of tetrodotoxin and are therefore considered TTX-sensitive (TTX-S). The remaining isoforms (NaV1.5, NaV1.8, NaV1.9) require micromolar tetrodotoxin for blockade and are therefore considered TTX-resistant (TTX-R).
3. Synthesis of crambescin B carboxylic acid, a potent inhibitor of voltage-gated sodium channels
Atsuo Nakazaki, Yuki Ishikawa, Yusuke Sawayama, Mari Yotsu-Yamashitab and Toshio Nishikawa*. Org. Biomol. Chem.,2014, 12,53–56
Considerable attention is currently devoted to the synthesis and properties of guanidine-containing natural products. Well-known examples of such compounds include tetrodotoxin and saxitoxin isolated as toxic principles of pufferfish intoxication and paralytic shellfish poison, respectively. These compounds exhibit potent blockage of sodium ion influx through voltage-gated sodium channels. Recently, we have focused on developing a subtype selective blocker of the sodium channels on the basis of natural products such as tetrodotoxin3 and saxitoxin. In this context, we were intrigued by the biological activities of carboxylic acid 2 of an alkaloid crambescin B isolated from the marine sponge Crambe crambe (Fig. 1), because of the similar zwitterion structure to tetrodotoxin; the spatial position of the guanidinium and carboxylate is similar to the guanidinium and orthoacid in tetrodotoxin (Fig. 2). Investigation of the biological activity of 2 has remained unexplored because crambescin B carboxylic acid 2 has not been isolated from natural sources and degradation of natural 1 into 2 has not been reported. Racemic synthesis of the twelve-carbon-chain homologue of carboxylic acid 2 has been reported by Snider et al.
4. Asymmetric synthesis of crambescin A–C carboxylic acids and their inhibitory activity on voltage-gated sodium channels
Atsuo Nakazaki, Yoshiki Nakane, Yuki Ishikawa, Mari Yotsu-Yamashitab and Toshio Nishikawa*. Org. Biomol. Chem.,2016, 14, 5304–5309
We investigated inhibitory activities on VGSCs of the six analogues, crambescin carboxylic acids 1a, 2 and 3 and crambescin B analogues 17, (+)-23 and (+)-24, by the cytotoxicity of ouabain and veratridine to mouse neuroblastoma cells (Neuro-2a), similar to the manner in which we previouslyestimated the activity of tetrodotoxin and its analogues (Table 1). Our previous studies demonstrated that racemic crambescin B carboxylic acid (±)-2 inhibited VGSCs with an EC50 value of 42 ± 25 nM, which was nine-fold larger than thatof tetrodotoxin (EC50 = 4.8 ± 2.6 nM). This study revealed that the natural dextro isomer was more potent than that of its enantiomer [(+)-2: 5.3 ± 2.2 nM vs. (−)-2: 79 ± 40 nM]. Moreover, this trend was also observed in all cases of crambescin A carboxylic acid 1a, crambescin C carboxylic acid 3 and decarboxylate 17; the EC50 for the natural dextro isomers was found to be more potent than those of each antipode.
2005 - BOC Sciences | All rights reserved
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE